 | Up a level |
Van Mieghem, Nicolas M; Unverdorben, Martin; Hengstenberg, Christian; Möllmann, Helge; Mehran, Roxana; López-Otero, Diego; Nombela-Franco, Luis; Moreno, Raul; Nordbeck, Peter; Thiele, Holger; Lang, Irene; Zamorano, José L; Shawl, Fayaz; Yamamoto, Masanori; Watanabe, Yusuke; Hayashida, Kentaro; Hambrecht, Rainer; Meincke, Felix; Vranckx, Pascal; Jin, James; ... (2021). Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 385(23), pp. 2150-2160. Massachusetts Medical Society 10.1056/NEJMoa2111016
Hamm, Christian W; Bassand, Jean-Pierre; Agewall, Stefan; Bax, Jeroen; Boersma, Eric; Bueno, Hector; Caso, Pio; Dudek, Dariusz; Gielen, Stephan; Huber, Kurt; Ohman, Magnus; Petrie, Mark C; Sonntag, Frank; Uva, Miguel Sousa; Storey, Robert F; Wijns, William; Zahger, Doron; ESC Committee, for Practice Guidelines; Bax, Jeroen J; Auricchio, Angelo; ... (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32(23), pp. 2999-3054. Oxford: Oxford University Press 10.1093/eurheartj/ehr236
